171 related articles for article (PubMed ID: 9304781)
1. The expression of nonagglutinating fimbriae and its role in Proteus mirabilis adherence to epithelial cells.
Tolson DL; Harrison BA; Latta RK; Lee KK; Altman E
Can J Microbiol; 1997 Aug; 43(8):709-17. PubMed ID: 9304781
[TBL] [Abstract][Full Text] [Related]
2. The effect of growth conditions on in vitro adherence, invasion, and NAF expression by Proteus mirabilis 7570.
Latta RK; Schur MJ; Tolson DL; Altman E
Can J Microbiol; 1998 Sep; 44(9):896-904. PubMed ID: 9851028
[TBL] [Abstract][Full Text] [Related]
3. Fimbriae of uropathogenic Proteus mirabilis.
Rocha SP; Pelayo JS; Elias WP
FEMS Immunol Med Microbiol; 2007 Oct; 51(1):1-7. PubMed ID: 17640292
[TBL] [Abstract][Full Text] [Related]
4. The binding of Proteus mirabilis nonagglutinating fimbriae to ganglio-series asialoglycolipids and lactosyl ceramide.
Lee KK; Harrison BA; Latta R; Altman E
Can J Microbiol; 2000 Oct; 46(10):961-6. PubMed ID: 11068685
[TBL] [Abstract][Full Text] [Related]
5. Tissue-binding affinity of Proteus mirabilis fimbriae in the human urinary tract.
Sareneva T; Holthöfer H; Korhonen TK
Infect Immun; 1990 Oct; 58(10):3330-6. PubMed ID: 1976113
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of nonagglutinating fimbriae and MR/P pili in swarming colonies of Proteus mirabilis.
Latta RK; Grondin A; Jarrell HC; Nicholls GR; Bérubé LR
J Bacteriol; 1999 May; 181(10):3220-5. PubMed ID: 10322025
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Proteus mirabilis structural fimbrial proteins as antigens against urinary tract infections.
Pellegrino R; Galvalisi U; Scavone P; Sosa V; Zunino P
FEMS Immunol Med Microbiol; 2003 May; 36(1-2):103-10. PubMed ID: 12727373
[TBL] [Abstract][Full Text] [Related]
8. Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection.
Bahrani FK; Johnson DE; Robbins D; Mobley HL
Infect Immun; 1991 Oct; 59(10):3574-80. PubMed ID: 1680106
[TBL] [Abstract][Full Text] [Related]
9. Galectin-3-mediated adherence of Proteus mirabilis to Madin-Darby canine kidney cells.
Altman E; Harrison BA; Latta RK; Lee KK; Kelly JF; Thibault P
Biochem Cell Biol; 2001; 79(6):783-8. PubMed ID: 11800020
[TBL] [Abstract][Full Text] [Related]
10. Mucosal vaccination of mice with recombinant Proteus mirabilis structural fimbrial proteins.
Scavone P; Sosa V; Pellegrino R; Galvalisi U; Zunino P
Microbes Infect; 2004 Jul; 6(9):853-60. PubMed ID: 15374007
[TBL] [Abstract][Full Text] [Related]
11. Mannose-resistant Proteus-like and P. mirabilis fimbriae have specific and additive roles in P. mirabilis urinary tract infections.
Zunino P; Sosa V; Schlapp G; Allen AG; Preston A; Maskell DJ
FEMS Immunol Med Microbiol; 2007 Oct; 51(1):125-33. PubMed ID: 17854474
[TBL] [Abstract][Full Text] [Related]
12. New aspects of the role of MR/P fimbriae in Proteus mirabilis urinary tract infection.
Zunino P; Geymonat L; Allen AG; Preston A; Sosa V; Maskell DJ
FEMS Immunol Med Microbiol; 2001 Aug; 31(2):113-20. PubMed ID: 11549418
[TBL] [Abstract][Full Text] [Related]
13. Proteus mirabilis uroepithelial cell adhesin (UCA) fimbria plays a role in the colonization of the urinary tract.
Pellegrino R; Scavone P; Umpiérrez A; Maskell DJ; Zunino P
Pathog Dis; 2013 Mar; 67(2):104-7. PubMed ID: 23620155
[TBL] [Abstract][Full Text] [Related]
14. Using Hemagglutination, Surface Shearing, and Acid Treatment to Study Fimbriae in Proteus mirabilis.
Himpsl SD; Pearson MM; Mobley HLT
Methods Mol Biol; 2019; 2021():109-120. PubMed ID: 31309500
[TBL] [Abstract][Full Text] [Related]
15. Requirement of MrpH for mannose-resistant Proteus-like fimbria-mediated hemagglutination by Proteus mirabilis.
Li X; Johnson DE; Mobley HL
Infect Immun; 1999 Jun; 67(6):2822-33. PubMed ID: 10338487
[TBL] [Abstract][Full Text] [Related]
16. Mannose-resistant Proteus-like fimbriae are produced by most Proteus mirabilis strains infecting the urinary tract, dictate the in vivo localization of bacteria, and contribute to biofilm formation.
Jansen AM; Lockatell V; Johnson DE; Mobley HL
Infect Immun; 2004 Dec; 72(12):7294-305. PubMed ID: 15557655
[TBL] [Abstract][Full Text] [Related]
17. Proteus mirabilis fimbriae (PMF) are important for both bladder and kidney colonization in mice.
Zunino P; Sosa V; Allen AG; Preston A; Schlapp G; Maskell DJ
Microbiology (Reading); 2003 Nov; 149(Pt 11):3231-3237. PubMed ID: 14600235
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of adherence of Actinomyces naeslundii (Actinomyces viscosus) T14V-J1 to saliva-treated hydroxyapatite by a monoclonal antibody to type 1 fimbriae.
Nesbitt WE; Beem JE; Leung KP; Stroup S; Swift R; McArthur WP; Clark WB
Oral Microbiol Immunol; 1996 Feb; 11(1):51-8. PubMed ID: 8604255
[TBL] [Abstract][Full Text] [Related]
19. Proteus mirabilis Overview.
Mobley HLT
Methods Mol Biol; 2019; 2021():1-4. PubMed ID: 31309490
[TBL] [Abstract][Full Text] [Related]
20. Expression of a nonagglutinating fimbria by Proteus mirabilis.
Tolson DL; Barrigar DL; McLean RJ; Altman E
Infect Immun; 1995 Mar; 63(3):1127-9. PubMed ID: 7868237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
